Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus
Journal Title: Endokrynologia, Diabetologia i Choroby Przemiany Materii Wieku Rozwojowego - Year 2005, Vol 11, Issue 3
Abstract
Background: Currently continuous subcutaneous insulin infusion (CSII) as a method of functional intensive insulin therapy is the most physiological way to administer insulin. In recent years treatment with insulin pumps has been used more frequently in the paediatric diabetes whereas application of this kind of therapy is relatively new in the youngest group of children below the age of 10 years. The aim of the study was to assess the efficiency of CSII by means of insulin pumps in prepubertal children with type 1 diabetes mellitus (T1DM). Materials and methods: Three groups of T1DM children on intensive insulin therapy were compared. Group 1 comprised 30 children with CSII in the mean age 6.7±2.2 SD years (CSII-1). In group 2 were 25 children treated with multiple injections (MI-1) in the mean age 7.0±1.5 SD years and in group 3-35 children in the mean age 13.9±2.1 SD years treated with CSII (group CSII-2). The age of children was comparable in group CSII-1 and MI-1. T1DM duration was the same for all groups. After 6, 12, 18 months the following parameters were analyzed,: HbA1c, daily insulin requirement (DIR) U/kg, number of severe hypoglycemic episodes and diabetic ketoacidosis (DKA). Results: After 18 months in CSII-1 HbA1c decreased insignificantly from 7.1% to 6.9% and DIR was significantly reduced from 0.86 U/kg/24 h to 0.7 U/kg/24 h (after 6 months) and to 0,75 U/kg/24 h (after 12 months) and 0.77 U/kg/24 h after 18 months. In the MI-1 group HbA1c increased significantly from 7.0% to 7.4% in the 6th month and to 7.3% in the 18th month. DIR increased significantly from 0.68 U/kg/24 h to 0.76 U/kg/24 h; 0,8 U/kg/24 h and 0.84 U/kg/24 h after 6, 12, and 18 months respectively. There were no significant differences in HbA1c and DIR values in CSII-2 group after 18 months of observation. Significant difference of DIR was found in: CSII-1 vs. MI-1 and CSII-2 (p
Authors and Affiliations
Mariola Minkina-Pędras, Przemysława Jarosz-Chobot, Ewa Małecka-Tendera, Grażyna Deja
Keywords
Related Articles
- EP ID EP83617
- DOI -
- Views 84
- Downloads 0
[True hermaphroditism in a 14-year-old boy--diagnostic and therapeutic difficulties]
The authors present a boy with a 46, XX/46, XY karyotype in whom true hermaphroditism was diagnosed, stressing the importance of establishing the cause of the condition and further management prior to discharging the neo...
Stan przednadciśnieniowy u dzieci i młodzieży chorej na cukrzycę typu 1
Wprowadzenie: Podwyższone ciśnienie tętnicze występujące u osób chorych na cukrzycę jest jednym z najważniejszych czynników ryzyka przewlekłych powikłań narządowych choroby. Cel pracy: Ocena częstości występowania stanu...
Adiponektyna – hormon tkanki tłuszczowej i jej związek z zespołem metabolicznym i chorobami układu krążenia
Adiponektyna jest jedną z aktywnych biologicznie substancji wydzielanych przez tkankę tłuszczową. Białko to odpowiedzialne jest za bilans energetyczny organizmu i bierze udział w zachowaniu homeostazy energetycznej. Wpły...
[The role of ghrelin in the regulation of energy homeostasis]
Ghrelin, a novel 28 amino acid peptide, is the endogenous ligand for the growth hormone secretagogue receptor. The stomach is the primary source of circulating ghrelin, but it is also produced by the intestines, kidneys,...
Rola polimorfizmu genu FTO w patogenezie otyłości
W patogenezie otyłości biorą udział zarówno czynniki środowiskowe jak i genetyczne. Aktualnie uwaga badaczy jest skupiona na podłożu genetycznym nadmiernej masy ciała. Obecnie uważa się, że istnieje związek między otyłoś...